Italy Blood Glucose Monitoring Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 647.77 Million |
| Market Size (2029) | USD 974.02 Million |
| CAGR (2024 - 2029) | 8.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Italy Blood Glucose Monitoring Market Analysis
The Italy Blood Glucose Monitoring Market size is estimated at USD 647.77 million in 2024, and is expected to reach USD 974.02 million by 2029, growing at a CAGR of 8.5% during the forecast period (2024-2029).
The rising number of diabetes cases in Italy is fueling the growth of the market for blood glucose monitoring devices in the forecasted period. Diabetes, a chronic disease characterized by high blood sugar levels, has become a significant health concern in Italy, with an increasing number of individuals being diagnosed with the condition. This surge in diabetes cases has created a demand for effective and efficient blood glucose monitoring devices to help individuals manage their condition.
Blood glucose monitoring devices play a crucial role in the management of diabetes by allowing individuals to regularly monitor their blood sugar levels. These devices provide accurate and real-time readings, enabling individuals to make informed decisions about their diet, medication, and lifestyle choices. With the rising prevalence of diabetes in Italy, there is a growing need for these devices to help individuals maintain optimal blood sugar levels and prevent complications associated with the disease.
The market for blood glucose monitoring devices in Italy is expected to witness significant growth in the forecasted period due to several factors. Firstly, the increasing awareness about diabetes and its management among the general population has led to a higher demand for blood glucose monitoring devices. Individuals are becoming more proactive in monitoring their health and are seeking reliable and user-friendly devices to assist them in managing their diabetes effectively.
Additionally, the increasing geriatric population in Italy, who are more susceptible to developing diabetes, has contributed to the growth of the market. As the elderly population continues to grow, there is a higher demand for blood glucose monitoring devices to cater to their specific needs and ensure effective diabetes management.
Furthermore, government initiatives and healthcare policies aimed at promoting diabetes awareness and prevention have also played a significant role in driving the market growth. These initiatives have increased the accessibility and affordability of blood glucose monitoring devices, making them more widely available to individuals with diabetes.
In conclusion, the rising number of diabetes cases in Italy has fueled the growth of the market for blood glucose monitoring devices in the forecasted period. Factors such as increasing awareness, technological advancements, the growing geriatric population, and government initiatives have contributed to the expansion of the market. As the prevalence of diabetes continues to rise, the demand for blood glucose monitoring devices is expected to further increase, creating opportunities for manufacturers
Italy Blood Glucose Monitoring Market Trends
Increasing Type-1 diabetes population across Italy
Diabetes mellitus affected nearly 3.8 million Italians in the current year. This was a significant increase from 2010 when 2.9 million people were affected by the disease. Over the ten years under consideration, the number of cases fluctuated along a general upward trend before peaking in 2022. The number of cases was proportional to the age of the patients. Diabetes was, in fact, much more common among the elderly than among the younger.
Diabetes mellitus will affect approximately 1.9 million people aged 65 to 74 and approximately 1.6 million aged 75 and up in Italy in 2022. Diabetes poses several challenges for both the NHS and Italian society. The greatest challenge is the rising prevalence of diabetes, which poses real health and economic threat to the Italian health system in the future. Prevalence has steadily increased over the last decade and is expected to rise further. It has been stated that if prevalence continues to rise at this rate, the future impact on society and the economy will be unsustainable.
The aging population and rising obesity are major contributors to rising prevalence. If an aging population is difficult. Obesity has increased in recent years, as evidenced by the AMD Annals, owing primarily to unhealthy lifestyle choices such as poor diet and insufficient physical activity. Obesity is so closely linked to diabetes that the two conditions have been dubbed "diabesity controlling." Meeting the demand for diabetes care is becoming increasingly difficult as diabetes prevalence rises, with diabetes centers struggling to care for an increasing number of diabetic patients even though diabetes centers are geographically distributed evenly.
About 10% of the Italian population has diabetes as of 2022. The rate of newly diagnosed Type 1 and Type 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products.
In May 2022, the World Health Assembly agreed on a Resolution on strengthening the prevention and control of diabetes. It recommends action in areas including increasing access to insulin, promoting convergence and harmonization of regulatory requirements for insulin and other medicines and health products for the treatment of diabetes, and assessing the feasibility and potential value of establishing a web-based tool to share information relevant to the transparency of markets for diabetes medicines and health products.
Continuous Glucose Monitoring Holds Highest CAGR in Italy Blood Glucose Monitoring Market.
The COVID-19 pandemic emphasized the need for good glycemic control in patients with diabetes, largely because most observational studies have reported that poorly controlled diabetes is associated with a higher risk of hospitalization and death from a viral illness. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. Type-1 diabetic patients need to check their blood glucose levels regularly to monitor their blood glucose levels and adjust the insulin dosing accordingly.
The current CGM devices show a detailed representation of blood glucose patterns and tendencies compared to a routine check of glucose levels at set intervals. Furthermore, the current continuous glucose monitoring devices can either retrospectively display the trends in blood glucose levels by downloading the data or give a real-time picture of glucose levels through receiver displays.
The use of CGM by Type-1 diabetic patients is very less as compared to Type-2 diabetic patients. But the expenditure of Type-1 diabetic patients on these devices is nearly double that of Type-2 diabetics. The newest CGM models, the Abbott Freestyle Libre and the Dexcom G6, overcame many technical barriers. However, high costs and uncertainties about their efficacy and necessity have kept CGM from being widely used by people with Type-2 diabetes. Continuous glucose monitoring devices are becoming cheaper with new technologies, like cell phone integration.
Italy Blood Glucose Monitoring Industry Overview
The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.
Italy Blood Glucose Monitoring Market Leaders
-
Roche
-
Abbott
-
Dexcom
-
Medtronics
-
LifeScan
*Disclaimer: Major Players sorted in no particular order
Italy Blood Glucose Monitoring Market News
- October 2023: Medtronic's Simplera is the most recent continuous glucose monitor (CGM) designed for individuals aged 2 and above who have diabetes. Currently undergoing FDA evaluation for approval in the United States, Simplera is an elegant, disposable device that eliminates the need for fingersticks. In Europe, Medtronic's latest CGM, Simplera, has already received approval.
- March 2022: DexCom announced the receipt of a CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.
Italy Blood Glucose Monitoring Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Drivers
- 4.3 Restraints
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Self-monitoring blood glucose devices
- 5.1.1 Glucometer Devices
- 5.1.2 Test Strips
- 5.1.3 Lancets
-
5.2 Continuous blood glucose monitoring devices
- 5.2.1 Sensors
- 5.2.2 Durables (Receivers and Transmitters)
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes population
- 6.2 Type-2 Diabetes population
7. COMPETITIVE LANDSCAPE
-
7.1 COMPANY PROFILES
- 7.1.1 Abbott Diabetes Care
- 7.1.2 Roche Holding AG
- 7.1.3 LifeScan
- 7.1.4 Dexcom Inc.
- 7.1.5 Medtronic PLC
- 7.1.6 Arkray Inc.
- 7.1.7 Ascensia Diabetes Care
- 7.1.8 Agamatrix Inc.
- 7.1.9 Bionime Corporation
- 7.1.10 Acon Laboratories Inc.
- 7.1.11 Trivida Functional Medicine
- 7.1.12 Senseonics
- *List Not Exhaustive
-
7.2 COMPANY SHARE ANALYSIS
- 7.2.1 Self-monitoring Blood Glucose Devices
- 7.2.1.1 Abbott Diabetes Care
- 7.2.1.2 Roche Holding AG
- 7.2.1.3 LifeScan
- 7.2.1.4 Others
- 7.2.2 Continuous Glucose Monitoring Devices
- 7.2.2.1 Dexcom Inc.
- 7.2.2.2 Medtronic PLC
- 7.2.2.3 Abbott Diabetes Care
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityItaly Blood Glucose Monitoring Industry Segmentation
Italy Blood Glucose Monitoring Market witnessed USD 0.5 billion in the current year and is anticipated to register a CAGR of over 5% during the forecast period. Italy Blood Glucose Monitoring Market is segmented into Type (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables). The report offers the value (in USD million) and volume (in Units million) for the above segments.
| Self-monitoring blood glucose devices | Glucometer Devices |
| Test Strips | |
| Lancets | |
| Continuous blood glucose monitoring devices | Sensors |
| Durables (Receivers and Transmitters) |
Italy Blood Glucose Monitoring Market Research FAQs
How big is the Italy Blood Glucose Monitoring Market?
The Italy Blood Glucose Monitoring Market size is expected to reach USD 647.77 million in 2024 and grow at a CAGR of 8.5% to reach USD 974.02 million by 2029.
What is the current Italy Blood Glucose Monitoring Market size?
In 2024, the Italy Blood Glucose Monitoring Market size is expected to reach USD 647.77 million.
Who are the key players in Italy Blood Glucose Monitoring Market?
Roche, Abbott, Dexcom, Medtronics and LifeScan are the major companies operating in the Italy Blood Glucose Monitoring Market.
What years does this Italy Blood Glucose Monitoring Market cover, and what was the market size in 2023?
In 2023, the Italy Blood Glucose Monitoring Market size was estimated at USD 592.71 million. The report covers the Italy Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Italy Blood Glucose Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Italy Blood Glucose Monitoring Industry Report
Statistics for the 2024 Italy Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Italy Blood Glucose Monitoring analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
